Failure mode and effects analysis in pharmaceutical research

Hirotaka Inoue, Shu Yamada

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Purpose – Quality management tools such as failure mode and effects analysis (FMEA) have been implemented in various industries to improve quality. This report aims to demonstrate that FMEA can be applied as a performance improvement tool, based on case analysis of process improvement conducted for a drug discovery project. Design/methodology/approach – The main points of the proposed FMEA process include: inclusion of an interface that makes it easy to visualize complicated processes in pharmaceutical research; identification of undesirable effects to indicate process defects; and a quantitative estimate of the undesirable effects related to quality and efficiency. Findings – The effectiveness of the proposed FMEA process was evaluated based on in vivo screening/profiling during early drug discovery. The process targeted for improvement was visualized using a flow diagram. The undesirable effects identified included waiting, false operations, and errors in the decisionmaking and reporting processes. The most serious flaws, determined by risk priority numbers for each category, were waiting and false operations. Originality/value – The effectiveness of the proposed FMEA was demonstrated by applying the analysis to another in vivo profiling process. Quantitative evaluation of the undesirable effects determined that they were reasonable. This provides a benefit for scientists seeking to improve the drug discovery process.

Original languageEnglish
Pages (from-to)369-382
Number of pages14
JournalInternational Journal of Quality and Service Sciences
Volume2
Issue number3
DOIs
Publication statusPublished - 2010 Oct 19
Externally publishedYes

Fingerprint

Failure modes and effects analysis
Pharmaceuticals
Drug discovery
Profiling
Diagrams
Process improvement
Design methodology
Performance improvement
Quality management
Defects
Quantitative evaluation
Case analysis
Screening
Management tools
Decision making
Industry
Inclusion

Keywords

  • Failure mode and effects analysis
  • Pharmaceuticals industry
  • Research

ASJC Scopus subject areas

  • Business, Management and Accounting (miscellaneous)

Cite this

Failure mode and effects analysis in pharmaceutical research. / Inoue, Hirotaka; Yamada, Shu.

In: International Journal of Quality and Service Sciences, Vol. 2, No. 3, 19.10.2010, p. 369-382.

Research output: Contribution to journalArticle

@article{14bfd94399ad46d1be0673f2f591a3aa,
title = "Failure mode and effects analysis in pharmaceutical research",
abstract = "Purpose – Quality management tools such as failure mode and effects analysis (FMEA) have been implemented in various industries to improve quality. This report aims to demonstrate that FMEA can be applied as a performance improvement tool, based on case analysis of process improvement conducted for a drug discovery project. Design/methodology/approach – The main points of the proposed FMEA process include: inclusion of an interface that makes it easy to visualize complicated processes in pharmaceutical research; identification of undesirable effects to indicate process defects; and a quantitative estimate of the undesirable effects related to quality and efficiency. Findings – The effectiveness of the proposed FMEA process was evaluated based on in vivo screening/profiling during early drug discovery. The process targeted for improvement was visualized using a flow diagram. The undesirable effects identified included waiting, false operations, and errors in the decisionmaking and reporting processes. The most serious flaws, determined by risk priority numbers for each category, were waiting and false operations. Originality/value – The effectiveness of the proposed FMEA was demonstrated by applying the analysis to another in vivo profiling process. Quantitative evaluation of the undesirable effects determined that they were reasonable. This provides a benefit for scientists seeking to improve the drug discovery process.",
keywords = "Failure mode and effects analysis, Pharmaceuticals industry, Research",
author = "Hirotaka Inoue and Shu Yamada",
year = "2010",
month = "10",
day = "19",
doi = "10.1108/17566691011090080",
language = "English",
volume = "2",
pages = "369--382",
journal = "International Journal of Quality and Service Sciences",
issn = "1756-669X",
publisher = "Emerald Group Publishing Ltd.",
number = "3",

}

TY - JOUR

T1 - Failure mode and effects analysis in pharmaceutical research

AU - Inoue, Hirotaka

AU - Yamada, Shu

PY - 2010/10/19

Y1 - 2010/10/19

N2 - Purpose – Quality management tools such as failure mode and effects analysis (FMEA) have been implemented in various industries to improve quality. This report aims to demonstrate that FMEA can be applied as a performance improvement tool, based on case analysis of process improvement conducted for a drug discovery project. Design/methodology/approach – The main points of the proposed FMEA process include: inclusion of an interface that makes it easy to visualize complicated processes in pharmaceutical research; identification of undesirable effects to indicate process defects; and a quantitative estimate of the undesirable effects related to quality and efficiency. Findings – The effectiveness of the proposed FMEA process was evaluated based on in vivo screening/profiling during early drug discovery. The process targeted for improvement was visualized using a flow diagram. The undesirable effects identified included waiting, false operations, and errors in the decisionmaking and reporting processes. The most serious flaws, determined by risk priority numbers for each category, were waiting and false operations. Originality/value – The effectiveness of the proposed FMEA was demonstrated by applying the analysis to another in vivo profiling process. Quantitative evaluation of the undesirable effects determined that they were reasonable. This provides a benefit for scientists seeking to improve the drug discovery process.

AB - Purpose – Quality management tools such as failure mode and effects analysis (FMEA) have been implemented in various industries to improve quality. This report aims to demonstrate that FMEA can be applied as a performance improvement tool, based on case analysis of process improvement conducted for a drug discovery project. Design/methodology/approach – The main points of the proposed FMEA process include: inclusion of an interface that makes it easy to visualize complicated processes in pharmaceutical research; identification of undesirable effects to indicate process defects; and a quantitative estimate of the undesirable effects related to quality and efficiency. Findings – The effectiveness of the proposed FMEA process was evaluated based on in vivo screening/profiling during early drug discovery. The process targeted for improvement was visualized using a flow diagram. The undesirable effects identified included waiting, false operations, and errors in the decisionmaking and reporting processes. The most serious flaws, determined by risk priority numbers for each category, were waiting and false operations. Originality/value – The effectiveness of the proposed FMEA was demonstrated by applying the analysis to another in vivo profiling process. Quantitative evaluation of the undesirable effects determined that they were reasonable. This provides a benefit for scientists seeking to improve the drug discovery process.

KW - Failure mode and effects analysis

KW - Pharmaceuticals industry

KW - Research

UR - http://www.scopus.com/inward/record.url?scp=84986135999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84986135999&partnerID=8YFLogxK

U2 - 10.1108/17566691011090080

DO - 10.1108/17566691011090080

M3 - Article

AN - SCOPUS:84986135999

VL - 2

SP - 369

EP - 382

JO - International Journal of Quality and Service Sciences

JF - International Journal of Quality and Service Sciences

SN - 1756-669X

IS - 3

ER -